Drug Safety Fears May Limit Reimporting and Shape R&D

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-02-02-2005
Volume 29
Issue 2

Concerns about risky medicines may reduce pressure to expand drug imports while boosting demand for more comparative analyses of therapies.

External Link - article-146233.pdf

Articles in this issue
Correcting the Course
Using Extrusion-Spheronization to Develop Controlled-Release Formulations of Azithromycin
Toward a Generic Approach for Stress Testing of Drug Substances and Drug Products
February 2005
Good Work and True: USP Prepares for Convention 2005
Contract Manufacturers Getting Squeezed
In the Spotlight-February 2005
Emerging Analytical Technology: Moving from the Lab to the Line
Drug Safety Fears May Limit Reimporting and Shape R&D
In Defense of USP Singlet Testing
Recent Videos
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Grants Fast Track Designation to Q32 Bio Treatment for Alopecia Areata

Patrick Lavery
April 30th 2025
Article

Bempikibart (ADX-914) is a human anti-IL-7Rα antibody that blocks the IL-7 and TSLP pathways, which have been implicated in driving T cell-mediated pathological processes in autoimmune diseases.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

CARBOGEN AMCIS Shanghai Site Gets Drug Manufacturing License from China’s NMPA

Patrick Lavery
April 24th 2025
Article
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Bavarian Nordic Chikungunya Vaccine Recommended by CDC's ACIP

Patrick Lavery
April 18th 2025
Article

The recombinant vaccine, under the brand name Vimkunya, is recommended for persons age 12 and older who are traveling to a country or territory where there is a chikungunya outbreak.

compounding pharmacist at work 2 | Image Credit: ©Nadia -stock.adobe.com

Pharmaceutical Compounding Calculations, Part One–Non-Salts, Salts, and Policy-Exception Salts

Paul L. Pluta;Nishant B. Thakar;Varanya Chaiyaperm
April 18th 2025
Article

Calculating the amount of drug needed for compounding requires different considerations for respective drug types and forms.